NextConsensus // Decision-window intelligence

Know when the window to challenge a claim is closing.

Evidence hardens before institutions act. We identify the evidence patterns that determine the Ratification Gap — so you can challenge claims while the window is still open.

For P&T committees, payer policy reviews, and coverage decisions: know when a disputed claim has reached a stable hardening pattern—and whether it is still safe to challenge.

One Claim To Challenge
One Decision P&T / Policy
Window Status Open / Closing

01 // THE PROBLEM

Evidence hardens before you vote.

By the time a P&T committee meets or a payer policy locks, the evidence surface may already be too stable to challenge. We identify these hardening points before the window closes.

[AUDIT_STATUS: MEASURED] · We identify hardening patterns, what holds, and whether the window to challenge is still open.

When this matters:

  • P&T committee docket reviews
  • Formulary exclusion challenges
  • Coverage policy reconsiderations
  • Prior authorization appeal windows
  • Guideline adoption deadlines

02 // THE OUTPUT

A challenge brief your team can forward to the committee.

Each brief answers: Can this claim still be challenged, and how much time do we have?

Window status (Open / Narrowing / Closing), what holds, what is under stress, what would reverse the read, and a suggested action envelope for your challenge strategy.

Challenge Brief Structure For P&T / Policy Review
  • Window Status: Open / Narrowing / Closing
  • What Holds: Stable evidence the challenge must overcome
  • What Is Under Stress: Weaknesses in the claim being advanced
  • What Would Reverse: Evidence that would reopen the window
  • Suggested Action Envelope: Challenge strategy before the window closes
Trust Boundary

We measure the Ratification Gap. We do not predict P&T votes or guarantee challenge success.

Start

Have a claim you need to challenge before a decision locks?

Send the claim, the decision date, and what is at stake. We respond within one business day with fit, limits, and whether the window to challenge is still open.

Requests require a verified institutional email address and are subject to current lane authorization limits.

Today's Read finerenone-cardiorenal
Hardening
Signal 0.38 / Gate 0.65
Phase 1b pending review. Other lanes: dossier-build.

Visual Debug

Page:

Width: px

Theme: